Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia

ABSTRACT Adherence to imatinib mesylate improves clinical outcomes and promotes a reduction in health expenditure. However, treatment duration and lack of efficacy decrease adherence to pharmacotherapy, resulting in increased mortality associated with Chronic Myeloid Leukemia. This study aimed to ev...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alexandra Rodrigues Alves, William Gustavo Lima, Michelly Martins Nagai, João Paulo Vilela Rodrigues, Lorena Rocha Ayres
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
coleção:	Brazilian Journal of Pharmaceutical Sciences
Assuntos:	Chronic Myeloid Leukemia/treatment Imatinib Mesylate/treatment adherence Medication adherence Pharmacotheraphy review.
Acesso em linha:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502016000400581&lng=en&tlng=en
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!